Accès gratuit
Numéro
Med Sci (Paris)
Volume 26, Numéro 3, Mars 2010
Page(s) 281 - 290
Section M/S revues
DOI https://doi.org/10.1051/medsci/2010263281
Publié en ligne 15 mars 2010
  1. French MA, Price P, Stone SF. Immune restoration disease after antiretroviral therapy. AIDS 2004; 18 : 1615–27.
  2. Shelburne SA, Hamill RJ, Rodriguez-Barradas MC, et al. Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy. Medicine 2002; 81 : 213–27.
  3. French MA. Immune reconstitution inflammatory syndrome: a reapparaisal. Clin Infect Dis 2009; 48 : 101–7.
  4. Chen VCC, Yuen KY, Wong SSY, et al. Immunorestitution diseases in patients not infected with HIV. Eur J Clin Microbiol Infect Dis 2001; 20 : 402–6.
  5. Singh N, Lortholary O, Alexander BD, et al. An immune reconstitution syndrome-like illness associated with cryptococcus neoformans infection in organ transplant recipients. Clin Infect Dis 2005; 40 : 1756–61.
  6. Micelli MH, Maertens J, Buvé K, et al. Immune reconstitution inflammatory syndrome in cancer patients with pulmonary aspergillosis recovering from neutropenia : proof of principle, description, and clinical and research implications. Cancer 2007; 110 : 112–20.
  7. Garcia-Vidal C, Rodriguez Fernandez S, Martinez Lacasa J, et al. Paradoxical response to antituberculous therapy in infliximab-treated patients with disseminated tuberculosis. Clin Infect Dis 2005; 40 : 756–9.
  8. Singh N, Perfect JR. Immune reconstitution syndrome and exacerbation of infections after pregnancy. Clin Infect Dis 2007; 45 : 1192–9.
  9. Breton G. Syndrome de reconstitution immunitaire chez les patients infectés par le VIH. La Lettre de l’Infectiologue 2006; 3 : 116–25.
  10. Meintjes G, Lawn S, Scanio F, et al. For the international network for the study of HIV-associated IRIS. Tuberculosis-associated immune reconstitution inflammatory syndrome: case definition for use in resource-limited settings. Lancet Infect Dis 2008; 8 : 516–23.
  11. Haddow LJ, Moosa MY, Easterbrook PJ. Validation of a published case definition for tuberculosis-associated immune reconstitution inflammatory syndrome. AIDS 2010; 24 : 103–8.
  12. Narita M, Ashkin D, Hollender ES, Pitchenik AE. Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS. Am J Respir Crit Care Med 1998; 158 : 157–61.
  13. Breton G. Immune reconstitution inflammatory syndrome. In: Schaaf SH, Zumla A, eds. Tuberculosis: a comprehensive clinical reference. New York : Saunders-Elsevier, 2009; 689–700.
  14. Lortholary O, Fontanet A, Némain N, et al. Incidence and risk factors of immune reconstitution inflammatory syndrome complicating HIV-associated cryptococcosis in France. AIDS 2005; 19 : 1043–9.
  15. Breton G, Adle-Biassette H, Therby A, et al. Immune reconstitution inflammatory syndrome in HIV-infected patients with disseminated histoplasmosis. AIDS 2006; 20 : 119–21.
  16. Legrand F, Lecuit M Dupont B, et al. Adjuvant corticosteroid therapy for chronic disseminated candidiasis. Clin Infect Dis 2008; 46 : 696–702.
  17. Bourgarit A, Carcelain G, Martinez V, et al. Explosion of tuberculin-specific Th1-responses induces immune restoration syndrome in tuberculosis and HIV co-infected patients. AIDS 2006; 20 : F1–7.
  18. Tan DB, Yong YK, Tan HY, et al. Immunological profiles of immune restoration disease presenting as mycobacterial lympadenitis and cryptococcal meningitis. HIV Med 2008; 9 : 307–16.
  19. Singh N, Lortholary O, Alexander BD, et al. Allograft loss in renal transplant recipients with Cryptococcus neoformans associated immune reconstitution syndrome. Transplantation 2005; 80 : 1131–3.
  20. Seddiki N, Sasson SC, Santaner-Nanan B, et al. Proliferation of weakly suppressive regulatory CD4 T cells is associated with over-active CD4 T cell response in HIV-positive patients with mycobacterial immune restoration disease. Eur J Immunol 2009; 39 : 391–403.
  21. Bourgarit A, Carcelain G, Samri A, et al. TB-associated immune restoration syndrome in HIV-1-infected patients involves tuberculin-specific CD4Th1 cells and can be predicted by KIR-negative gd T cells. Montreal : 16th Conference on retroviruses and opportunistic infections, 2009 (abstract 772).
  22. Price P, Morahan G, Huang D, et al. Polymorphisms in cytokine genes define subpopulations of HIV-1 patients who experienced immune restoration diseases. AIDS 2002; 16 : 2043–7.
  23. Vendrely A, Bienvenu B, Gasnault J, et al. Fulminant inflammatory leukoencephalopathy associated with HAART-induced immune restoration in AIDS-related progressive multifocal leukoencephalopathy. Acta Neuropathol 2005; 109 : 449–55.
  24. Egli A, Bergamin O, Müllhaupt B, et al. Cytomegalovirus-associated chorioretinitis after liver transplantation: case report and review of the literature. Transpl Infect Dis 2008; 10 : 27–43.
  25. Bochud PY, Hawn TR, Siddiqui MR, et al. Toll-like receptor 2 polymorphisms are associated with reversal reaction in leprosy. J Infect Dis 2008; 197 : 253–61.
  26. Lawn SD, Myer L, Bekker LG, et al. Tuberculosis associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa. AIDS 2007; 21 : 335–41.
  27. Manabe YC, Cambell JD, Sydnor E, et al. Immune reconstitution inflammatory syndrome: risk factors and treatment implications. J Acquir Immune Defic Syndr 2007; 46 : 456–62.
  28. Murdoch DM, Venter WDF, Feldman C, Van Rie A. Incidence and risk factors for the immune reconstitution inflammatory syndrome in HIV patients in south Africa: a prospective study. AIDS 2008; 22 : 601–10.
  29. Cheng VCC, Yam WC, Woo PCY, et al. Risk factors for development of paradoxical response during antituberculosis therapy in HIV-negative patients. Eur J Clin Microbiol Infect Dis 2003; 22 : 597–602.
  30. Azoulay E, Darmon M, Delchaux C, et al. Deterioration of previous acute lung injury during neutropenia recovery. Crit Care Med 2002; 30 : 781–6.
  31. Shelburne SA, Visnegarwala F, Darcourt, et al. Incidence and risk factors for immune reconstitution inflammatory syndrome during higly active antiretroviral therapy. AIDS 2005; 19 : 399–406.
  32. Breton G, Duval X, Estellat C, et al. Determinants of immune reconstitution inflammatory syndrome in HIV type 1-infected patients with tuberculosis after initiation of antiretroviral therapy. Clin Infect Dis 2004; 39 : 1709–12.
  33. Cinque P, Bossolasco S, Brambilla AM, et al. The effect of HAART-induced immune reconstitution on development and outcome of progressive multifocal encephalopathy : study of 43 cases with review of the litterature. J Neurovirol 2003; 9 : 73–80.
  34. Tan K, Roda R, Ostrow L, Mc Arthur J, Nath A. PML-IRIS in patients with HIV infection. Clinical manifestations and treatment with steroids. Neurology 2009; 72 : 1458–64.
  35. Cheng VCC, Ho PL, Lee RA, et al. Clinical spectrum of paradoxical deterioration during antituberculosis therapy in non-HIV-infected patients. Eur J Clin Microbiol Infect Dis 2002; 21 : 803–9.
  36. Cheng VCC, Woo PCY, Lau SKP, et al. Peripartum tuberculosis as a form of immunorestitution disease. Eur J Clin Microb Infect Dis 2003; 22 : 313–7.
  37. Park WB, Choe PG, Jo JH, et al. Immune reconstitution inflammatory syndrome in the first year after HAART: influence on long term outcome. AIDS 2006; 20 : 2390–2.
  38. Kaplan JE, Benson C, Homes KK, Brooks JT, Masur TT. Guidelines for prevention and treatment of opportunistics infections in HIV-infected adults and adolescents. Morb Mortal Wkly Rep (MMWR) 2009; 58 : 1–198.
  39. Meintjes G, Wilkinson R, Morroni C, et al. Randomiszed placebo-controlled trial of prednisone for the TB IRIS. Montreal : 16th Conference on retroviruses and opportunistic infections, 2009 (abstract 34).
  40. Zolopa A, Anderson J, Komarow L, et al. Immediate versus deferred ART in the setting of acute AIDS-related opportunistic infection: final results of a randomized strategy trial, ACTG 5164. Boston : 15th Conference on retroviruses and opportunistic infections, 2008 (abstract 142).
  41. Catros V, Bouet F, Cabillic F, et al. Lymphocytes T gamma delta en cancérologie : des lymphocytes tueurs non conventionnels. Med Sci (Paris) 2010; 26 : 185–93.
  42. Leung-Theung-Long S, Guerder S. Les cellules Th17 : une nouvelle population de cellules T CD4 effectrices pro-inflammatoires.Med Sci (Paris) 2008; 24 : 972–6.

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.